North America PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User

List of Tables

The North America PCR technologies market is expected to grow from US$ 5,075.81 million in 2022 to US$ 9,634.86 million by 2030. It is estimated to record a CAGR of 8.3%from 2022 to 2030.

Advancements in PCR Technologies Fuel North America PCR Technologies Market

The advantages of PCR such as exquisite sensitivity, relative simplicity, and cost-effectiveness have tremendously added to its popularity in the past years. The PCR technology has evolved significantly, resulting in more specific workflows for a wide variety of applications. The use of PCR technology is being explored into several nonconventional applications, making molecular diagnosis easier and faster. Advancements in dPCR and RT-PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST) announced the development of an ultrafast PCR technology. The development project was led by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung's research team. The ultrafast PCR reduces the test duration by 10 times compared to the previous tests by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to existing test methods, and it can be finished in 5 minutes. In January 2021, Danaher Corporation announced that Health Canada issued a medical device license to Cepheid for Xpert Xpress SARS-CoV-2/Flu/RSV. A few of the technological advancements by companies in the PCR technologies market are as given, In March 2021, PCR Biosystems announced the launch of its IsoFast Bst polymerase reagents, which support sensitive, robust, and rapid amplification of RNA and DNA, enabling faster testing procedures. In October 2021, Thermo Fisher Scientific introduced the Applied Biosystem Quantstudio Absolute Q-Digital PCR System, the first fully integrated dPCR system designed to deliver highly accurate and consistent genetic analysis. The company claims that the product generates research results within 90 minutes. In May 2022, Bio-Rad Laboratories, Inc. introduced its CFX Duet Real-Time PCR System in selected countries that accept the CE Mark. The system is intended to support researchers in developing singleplex and duplex qPCR assays. In November 2022, PCR Biosystems launched new qPCR reagent mixes-Clara Probe Mix, Clara Probe 1-Step Mix, and Clara HRM Mix. In November 2022, Cepheid launched the Xpert Xpress MVP multiplex PCR test. The test helps detect DNA from organisms that are associated with three distinct conditions, namely, bacterial vaginosis (BV), trichomoniasis, and vulvovaginal candidiasis, from a single sample, aiding in more precise diagnosis and supporting accurate antibiotic treatment regimens. Thus, such advancements are expected to bring new trends into the PCR technologies market in the coming years.

North America PCR Technologies Market Overview

The North America PCR technologies market is segmented into the US, Canada, and Mexico. Market growth in this region is attributed to the increased demand for innovative products from bioanalytical instrument manufacturers and PCR companies, the presence of key market players, and extensive R&D conducted across various academic and research institutes. In addition, the well-known practice of adopting medical devices in healthcare operations to improve quality and reduce costs also benefits the PCR technologies market in the US and other North American countries. An upsurge in the acceptance and adoption of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that aid in rapid quantification, alterations, and observation. The emergence of digital PCR in the form of droplet digital PCR offers new opportunities for screening, providing superior sensitivity and easy adaptability. The US is seeking significant funding from public and private organizations to encourage investments in advanced research methodologies. For instance, the International Centre for Genetic Engineering and Biotechnology aims to stimulate collaborative research in the member states. It receives funds through the Collaborative Research Programme (CRP) that aims to address original scientific problems of relevance and interest. Advancements in biotechnology that depend on PCR techniques to help improve human health, animal welfare, and food security. The US Food and Drug Administration (USFDA) is committed to ensuring the safety of biotechnology products. The US actively participates in various research groups and organizations to conduct scientific conferences, workshops, and events that help exchange the trends and latest research studies based on PCR within different geographies. Therefore, the country's active involvement is also one of the factors driving the growth of the PCR technologies market.

North America PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

North America PCR Technologies Market Segmentation

The North America PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the North America PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of North America PCR technologies market in 2022.

In terms of offerings, the North America PCR technologies market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of North America PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR and portable thermocyclers/PCR.

By application, the North America PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of North America PCR technologies market in 2022.

Based on end user, the North America PCR technologies market is categorized into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of North America PCR technologies market in 2022.

By country, the North America PCR technologies market has been categorized into the US, Canada, and Mexico. The US dominated the North America PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Atila Biosystems Inc, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, Visby Medical Inc, and Ellume Ltd are some of the leading companies operating in the North America PCR technologies market.

Product Code: BMIRE00030517

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America PCR Technologies Market - Key Industry Dynamics

4.1 PCR Technologies Market - Key Industry Dynamics
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
- 4.2.2 Surging Investments and Funds Availability for PCR Technologies
4.3 Market Restraints
- 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
- 4.4.1 Increasing Demand for POC Testing
4.5 Future Trends
- 4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - North America Market Analysis

5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. North America PCR Technologies Market Analysis - By Technology

6.1 Overview
6.2 Real Time PCR
- 6.2.1 Overview
- 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
- 6.3.1 Overview
- 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
- 6.4.1 Overview
- 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
- 6.5.1 Overview
- 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
- 6.6.1 Overview
- 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
- 6.7.1 Overview
- 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
- 6.8.1 Overview
- 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. North America PCR Technologies Market Analysis - By Offerings

7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
- 7.3.1 Overview
- 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
    - 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
7.4 Instruments
- 7.4.1 Overview
- 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
7.5 Software and Services
- 7.5.1 Overview
- 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. North America PCR Technologies Market Analysis - By Application

8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
- 8.3.1 Overview
- 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
- 8.4.1 Overview
- 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
- 8.5.1 Overview
- 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
- 8.6.1 Overview
- 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
- 8.7.1 Overview
- 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
- 8.8.1 Overview
- 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
- 8.9.1 Overview
- 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
- 8.10.1 Overview
- 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. North America PCR Technologies Market Analysis - By End User

9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
- 9.3.1 Overview
- 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
- 9.4.1 Overview
- 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
- 9.5.1 Overview
- 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. North America PCR Technologies Market - Country Analysis

10.1 North America: PCR Technologies Market
- 10.1.1 Overview
- 10.1.2 North America PCR Technologies Market Revenue and Forecast and Analysis - By Country
  - 10.1.2.1 United States
    - 10.1.2.1.1 Overview
  - 10.1.2.2 United States PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.2.1 United States PCR Technologies Market Breakdown by Technology
    - 10.1.2.2.2 United States PCR Technologies Market Breakdown by Offerings
    - 10.1.2.2.2.1 United States PCR Technologies Market Breakdown by Instruments
    - 10.1.2.2.2.2 United States PCR Technologies Market Breakdown by Reagents and Consumables
    - 10.1.2.2.2.2.1 United States PCR Technologies Market Breakdown by Vial Size
    - 10.1.2.2.3 United States PCR Technologies Market Breakdown by Application
    - 10.1.2.2.4 United States PCR Technologies Market Breakdown by End User
  - 10.1.2.3 Canada
    - 10.1.2.3.1 Overview
  - 10.1.2.4 Canada PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.4.1 Canada PCR Technologies Market Breakdown by Technology
    - 10.1.2.4.2 Canada PCR Technologies Market Breakdown by Offerings
    - 10.1.2.4.2.1 Canada PCR Technologies Market Breakdown by Instruments
    - 10.1.2.4.2.2 Canada PCR Technologies Market Breakdown by Reagents and Consumables
    - 10.1.2.4.2.2.1 Canada PCR Technologies Market Breakdown by Vial Size
    - 10.1.2.4.3 Canada PCR Technologies Market Breakdown by Application
    - 10.1.2.4.4 Canada PCR Technologies Market Breakdown by End User
  - 10.1.2.5 Mexico
    - 10.1.2.5.1 Overview
  - 10.1.2.6 Mexico PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.6.1 Mexico PCR Technologies Market Breakdown by Technology
    - 10.1.2.6.2 Mexico PCR Technologies Market Breakdown by Offerings
    - 10.1.2.6.2.1 Mexico PCR Technologies Market Breakdown by Instruments
    - 10.1.2.6.2.2 Mexico PCR Technologies Market Breakdown by Reagents and Consumables
    - 10.1.2.6.2.2.1 Mexico PCR Technologies Market Breakdown by Vial Size
    - 10.1.2.6.3 Mexico PCR Technologies Market Breakdown by Application
    - 10.1.2.6.4 Mexico PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Thermo Fisher Scientific Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Promega Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 QIAGEN NV
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 bioMerieux SA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Becton Dickinson and Co
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Atila Biosystems Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Takara Bio Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Standard Biotools Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Agilent Technologies Inc
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Visby Medical Inc
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Ellume Ltd
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments

13. Appendix

13.1 About the Insight Partners
13.2 Glossary of Terms